Back to top
more

BioTechne Corp (TECH)

(Delayed Data from NSDQ)

$80.60 USD

80.60
969,063

+1.93 (2.45%)

Updated Jul 26, 2024 04:00 PM ET

After-Market: $80.59 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Sesen Bio (SESN) Looks Good: Stock Adds 6.2% in Session

Sesen Bio (SESN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Alexion (ALXN) Catches Eye: Stock Jumps 6.8%

Alexion (ALXN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Reasons to Invest in Dr. Reddy's (RDY) Amid Coronavirus Woes

Dr. Reddy's (RDY) continues to make products launches despite tepid sales volumes due to the COVID-19 pandemic.

5 Reasons to Invest in Horizon Therapeutics Amid Coronavirus

Horizon Therapeutics (HZNP) expects continued strong growth for Krystexxa and Tepezza, going forward in 2020. The company's efforts to develop its pipeline are impressive.

Syros (SYRS) in Focus: Stock Moves 7.9% Higher

Syros (SYRS) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Agenus (AGEN) in Focus: Stock Moves 7.6% Higher

Agenus (AGEN) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Intercept (ICPT) Catches Eye: Stock Jumps 8.4%

Intercept (ICPT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Earnings Preview: Techne (TECH) Q4 Earnings Expected to Decline

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Techne (TECH) a Solid Growth Stock? 3 Reasons to Think " Yes "

Techne (TECH) could produce exceptional returns because of its solid growth attributes.

REGN vs. TECH: Which Stock Is the Better Value Option?

REGN vs. TECH: Which Stock Is the Better Value Option?

LGND or TECH: Which Is the Better Value Stock Right Now?

LGND vs. TECH: Which Stock Is the Better Value Option?

LGND vs. TECH: Which Stock Should Value Investors Buy Now?

LGND vs. TECH: Which Stock Is the Better Value Option?

Techne (TECH) Tops Q3 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of 23.01% and 5.31%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

REGN vs. TECH: Which Stock Should Value Investors Buy Now?

REGN vs. TECH: Which Stock Is the Better Value Option?

Techne (TECH) Lags Q2 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of -5.26% and -3.50%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GILD vs. TECH: Which Stock Should Value Investors Buy Now?

GILD vs. TECH: Which Stock Is the Better Value Option?

CELG vs. TECH: Which Stock Is the Better Value Option?

CELG vs. TECH: Which Stock Is the Better Value Option?

Techne (TECH) Q1 Earnings Lag Estimates

Techne (TECH) delivered earnings and revenue surprises of -0.93% and 1.77%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for August 15th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

Techne (TECH) Q4 Earnings and Revenues Lag Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.58% and -3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?

Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

Better-than-expected performance at Pharmaceutical and Medical segments are likely to aid Cardinal Health's (CAH) in Q4 earnings.